了解本次路演活动，请点击： 浙江海圣医疗器械股份有限公司向不特定合格投资者公开发行股票并在北交所上市网上路演于2026年2 月3日14:00-16:00在全景路演举行。 路演现场，公司方在回复投资者提问时表示，公司核心技术的产业化应用成效显著。针对传统医疗产品 存在的操作不便、性能不佳、交叉感染等诸多技术难题，公司通过技术创新让产品在安全性、小型化、 数据精度以及用户体验方面具备突出行业优势。公司产品可灵活适用于多种复杂的临床应用场景，深度 覆盖不同科室的多样化需求。有效提升医护人员的工作效率，增强下游客户的产品使用黏性。 ...

为减轻患者医疗负担，推动医疗机器人技术发展，近年来，北京、上海、湖南、广东等省市陆续将手术机器人及相关耗材等项目纳入医保支付范 围。比如北京医保规定，机器人手术费用报销限额为8000元，也就是说在8000元的范围内可以全额报销。而一次性耗材医保可报销70%。纳入医保 之后，机器人手术的个人自费部分由之前的3万元-4万元下降到1万元左右。 转载请注明央视财经 编辑：潘煦 国家医保局从立项、定价等方面入手，畅通新技术的收费通道，助力满足临床急需的新技术新产品加快收益回报。目前已公布的37批立项指南新 增涉及新产品新技术的价格项目100多项，基本形成"价格立项与技术创新并行"的格局。比如：神经系统类立项指南统一设立"脑机接口置入费""脑 机接口适配费"等价格项目，助推脑机接口技术快速进入临床应用并收费。 （央视财经《正点财经》）截至目前，我国已先后发布37批医疗服务价格项目立项指南，新增100多项与医疗新技术相关的价格项目。2026年国家 医保局还将完成3批医疗服务价格项目立项指南编制工作。 ...

Group 1 - The National Healthcare Security Administration has released a guideline for pricing surgical robots and other advanced medical technologies, establishing a clear framework for charges, which includes 37 pricing items and additional categories for remote surgery and 3D printing [1][2] - The guideline emphasizes innovation by allowing for reasonable premiums on advanced products based on their clinical value and participation in surgeries, breaking traditional limitations related to surgical access and application sites [1][3] - The introduction of a "remote surgery assistance fee" enables experts in resource-rich areas to provide services to patients in different locations, promoting the accessibility of high-quality medical care [1][3] Group 2 - Specific pricing projects for 3D printing and imaging technologies have been established, facilitating the clinical application of bioprinting and enhancing surgical precision through new navigation assistance [2][3] - The guideline aims to protect patients' financial interests by implementing a "choose one" principle for disposable and reusable surgical materials, encouraging the use of cost-effective reusable options [3] - The guideline is expected to stimulate innovation in the medical technology sector, encouraging companies to develop advanced surgical robots and other technologies, thereby benefiting patients [3]

Core Viewpoint - The successful application of the neurosurgical robot at Faku Mining General Hospital represents a significant advancement in precision surgery, enhancing patient safety and recovery outcomes while being recognized by multiple national media outlets [1][4]. Group 1: Surgical Precision and Patient Outcomes - The neurosurgical robot operates with a precision of 0.2-0.6 millimeters, redefining the risk boundaries in complex surgical areas such as the trigeminal ganglion and cranial base [1]. - In just two months, the system has assisted in over twenty high-difficulty minimally invasive surgeries, with all patients showing good postoperative outcomes [2]. - The robot is effective not only for trigeminal neuralgia but also for conditions like cerebral hemorrhage and complex functional lesions, significantly reducing the risk of blind punctures [2]. Group 2: Training and Technology Development - The neurosurgical robot serves as a clinical tool and an accelerator for the growth of young medical professionals, with weekly case discussions and monthly technical training sessions [3]. - The hospital has pioneered the use of robot-assisted precise minimally invasive treatments for cerebral hemorrhage, ensuring strong postoperative neurological recovery [3]. - The collaboration with China Resources Health Group allows for the sharing of surgical cases, quality control standards, and training courses, enhancing the safety and effectiveness of the technology [3]. Group 3: Institutional Integrity and Quality Assurance - Faku Mining General Hospital is part of the China Resources Health Group, a state-owned enterprise, and is not a privately acquired institution, ensuring its commitment to public health [3]. - The hospital's operational model aims to provide more professional, effective, economical, and considerate medical services, contributing to regional healthcare standardization [3]. Group 4: Comprehensive Health Management - The hospital provides health guidelines for patients, emphasizing the importance of timely medical consultation for symptoms like facial pain or sudden paralysis [5][6]. - Postoperative care includes imaging reassessment, functional training, and long-term follow-up as per medical advice [7]. Group 5: Commitment to Public Health - The precision of the surgical procedures and the replicable training system reflect the hospital's commitment to public health, aligning with the mission of the state-owned enterprise to enhance healthcare quality [8].

Group 1 - The 36th Italian Digestive Surgery Annual Meeting was successfully held in Rome from November 27 to 28, attracting nearly 3,000 on-site participants and over 13,000 online attendees, showcasing its significant academic influence globally [1][17] - The meeting featured continuous live surgeries over two days, with more than 6,000 surgeries broadcasted and over 3,000 lead surgeons participating, highlighting the increasing role of Chinese doctors in the field [3][17] - The event served as a high-level international exchange platform, with 11 Chinese experts demonstrating complex surgical techniques in areas such as gastrointestinal tumors and hepatobiliary surgery, showcasing China's technical strength and teamwork [3][17] Group 2 - The live surgeries included various complex procedures, such as the external liver resection and autologous transplantation by the team led by Academician Dong Jiahong, which received high praise for its precision and teamwork [4][21] - The Shanghai Jiao Tong University School of Medicine's team, led by Professor Shen Baiyong, successfully performed a robotic pancreaticoduodenectomy, further demonstrating the advanced surgical capabilities of Chinese medical teams [13][28] - The event not only showcased high-level surgical demonstrations but also facilitated real-time interactions and in-depth discussions among international experts, enhancing the academic dialogue [28] Group 3 - As a leading enterprise in the Chinese pharmaceutical industry, Heng Rui Medicine has established a bridge for high-level exchanges in digestive surgery, contributing to the global recognition of Chinese medical technology [3][14] - The company has invested over 50 billion yuan in research and development as of the end of Q3 2025, positioning itself among the top Chinese pharmaceutical companies [14][29] - Heng Rui Medicine has received approval for 24 class 1 innovative drugs in China and has over 100 self-developed products in clinical development, demonstrating its commitment to innovation and global competitiveness [14][29]

Core Points - The article announces the continuation of the Global MedTech Awards by Suyu MedTech to promote technological innovation and help innovative companies gain influence starting from 2023 [2] - A supplementary call for entries for innovative companies and products for the year 2025 will be open until the end of 2025 [2] Award Categories and Evaluation Criteria - **Global MedTech Industry Contribution Award**: Targeting leading medical technology companies with approved products widely used in hospitals, demonstrating significant contributions in clinical application, product innovation, economic, and social benefits [4] - **Global Medical Technology Innovation Award**: Aimed at companies with outstanding performance in medical technology innovation, focusing on products or solutions that enhance medical efficiency, improve diagnosis and treatment outcomes, and have market potential and social value [5] - **Global MedTech Rising Star Award**: For growing medical technology companies with unique technological innovation capabilities and strong market development potential [6] - **Global Innovation Medical Device Award**: For innovative medical devices approved by NMPA, FDA, or CE within 2025, recognized for their design, technology, and functionality [7] Application and Selection Process - **Application Phase**: Open from now until December 7, 2025, at 6 PM, where institutions can voluntarily submit their application materials [8] - **Selection Phase**: From now until December 15, 2025, the evaluation committee will review submissions and may contact companies for additional information [8] - **Award Notification**: Expected by December 22, 2025, with results published in an article [9] - **Award Ceremony**: Scheduled for July 2026 at the Zhongguancun Exhibition Center, with further details to be announced [9] Additional Information - Participation in the awards is free of charge, and companies that have previously submitted applications for the first batch should not resubmit [10]

Core Viewpoint - Yian Technology (宜安科技) is actively expanding its strategic layout in the metal new materials sector, focusing on the construction of its Zhuzhou factory, the application of liquid metal, the development of its robotics business, and the progress of its Mexico base, showcasing its technological accumulation and multi-dimensional strategy in the industry [1][2][4]. Group 1: Zhuzhou Factory and Liquid Metal - The Zhuzhou factory is a key component of Yian Technology's strategic layout, with construction progressing smoothly and the factory building completed, initiating the delivery process [2]. - The factory is positioned to be a leading global production base for amorphous alloys (liquid metal), which will significantly enhance the company's production capacity and alleviate current bottlenecks in high-end precision structural components [2]. - Liquid metal is a core business for Yian Technology, with applications in consumer electronics, where the company has established a strong reputation for reliability and structural support, particularly with early adopters in the foldable smartphone market [2][4]. Group 2: Robotics and Mexico Base - Yian Technology has established a robotics division to align with the rapid development of the robotics industry, leveraging its advantages in aluminum-magnesium alloys and precision structural components [3]. - The company is implementing a three-step strategy for its Mexico base, which includes establishing a marketing and transit delivery base, a small-scale production base, and a large die-casting base, aimed at enhancing its global competitiveness and market share [3]. - The construction of the Mexico base is a significant move for Yian Technology's globalization strategy, allowing closer proximity to North American customers and reducing trade barriers [3]. Group 3: Medical Devices and Overall Strategy - The magnesium bone screw products in the medical device sector are highlighted as a promising business area, with significant market demand despite not yet achieving mass production [4]. - Yian Technology's multi-dimensional and resilient business matrix spans liquid metal, robotics, overseas bases, and medical devices, aligning with key trends in consumer electronics, robotics, globalization, and medical technology innovation [4]. - As the Zhuzhou factory's capacity is gradually released and the Mexico base progresses, Yian Technology is expected to benefit from the rapid development of related industries [4].

Core Viewpoint - Brazil is seeking to enhance healthcare cooperation with China, aiming to learn from China's advanced experiences to improve health services and the healthcare system's adaptability to climate change [1] Group 1: Healthcare Cooperation - Brazil's Health Minister Padilha expressed the country's willingness to strengthen medical and health cooperation with China [1] - During a visit to China in October, Padilha toured a facility producing dengue fever vaccines and a smart hospital utilizing information technology and artificial intelligence for patient services [1] Group 2: Technological Innovation - Brazil aims to adopt advanced technologies from China in areas such as smart hospitals, vaccine production, and pharmaceutical manufacturing to improve public health [1] - The Brazilian Health Ministry is focused on promoting medical technology innovation to enhance the capacity to respond to natural disasters like hurricanes, floods, droughts, extreme heat, and wildfires [1] Group 3: Community Health Initiatives - In the Amazon region, the Brazilian government is implementing measures such as retrofitting medical ships, utilizing digital technology, and telemedicine to serve local communities [1] - The initiatives aim to improve health levels among residents in remote areas and vulnerable populations [1]

Core Insights - The Jiangsu province is enhancing its healthcare services through innovative medical technologies and improved patient experiences, as evidenced by the inclusion of advanced medical techniques in the national "Good Technology" project [1][2] - The focus on high-quality development in public hospitals aims to meet the health needs of the population by improving medical technology, service models, and patient experiences [1][3] Group 1: Medical Innovations - Two medical technologies from Zhenjiang's hospitals have been recognized in the national "Good Technology" project, showcasing the city's commitment to healthcare innovation [1] - The Zhenjiang First People's Hospital successfully performed a complex finger reconstruction surgery using advanced techniques, marking a significant achievement in local medical capabilities [2][3] Group 2: Public Hospital Development - Zhenjiang is prioritizing the development of specialized capabilities in public hospitals, with multiple national and provincial key specialty units established to enhance healthcare services [3][4] - The integration of traditional Chinese medicine into modern healthcare practices is being emphasized, with new initiatives to promote its application in various medical conditions [4] Group 3: Patient Experience Improvements - The implementation of a health cloud platform allows for the sharing of medical imaging and test results across multiple healthcare facilities, significantly improving patient convenience [5][6] - Community health centers are enhancing patient access to specialists through innovative appointment systems and telemedicine, reducing the need for patients to travel for care [7][8] Group 4: Community Health Initiatives - The "Service for People's Health Action" initiative by Zhenjiang First People's Hospital aims to provide accessible healthcare services in local communities, addressing the challenges of distance and specialist availability [8] - A series of measures have been introduced to streamline healthcare processes and improve patient satisfaction, including free follow-up visits and reduced medical fees [8][9] Group 5: Future Directions - The Zhenjiang health authority is committed to establishing a regional medical center and enhancing public hospital reforms to ensure high-quality healthcare delivery [10]

Core Points - The company Jin Hai Medical Technology (02225) is preparing to participate in the 8th China International Import Expo (CIIE) scheduled for November 5-10, 2025, in Shanghai [1] - During the expo, Jin Hai Medical will jointly launch innovative navigation-based spinal endoscopy technology with Medtronic China, aimed at enhancing precision and intelligence in spinal surgeries [1] - Medtronic is a leading global medical technology company, operating in over 150 countries with more than 90,000 employees [1][2] Company Overview - Medtronic's primary business includes the development, manufacturing, distribution, and sales of medical therapies and services in cardiovascular, neuroscience, surgical, and diabetes fields [2] - Medtronic has established production bases in Shanghai, Changzhou, and Chengdu, China [2] - Since the first CIIE in 2018, Medtronic has participated in the event for seven consecutive years, leveraging its influence to showcase and accelerate the application of its latest innovative medical technologies and products [2]